Urea Cycle Disorders
Once-Fatal Metabolic Disorders Treatable, Says Stanford/Packard Researcher
Published in Drug Law Weekly, June 12th, 2007
The researchers found in their unprecedented 25-year study that prompt diagnosis coupled with a rapid start of intravenous drug therapy significantly improves the survival rates of people with the condition, called urea cycle disorders. The condition affects proteins in the liver that are necessary to process the by-products of protein metabolism.
"Historically, the prognosis for patients with urea cycle disorders...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Law Weekly
Source: Drug Law Weekly (2007-06-12)
More Articles from Drug Law Weekly
- Allos Therapeutics
Allos Therapeutics Files Shelf Registration Statement - Cancer Vaccines
Did the Food and Drug Administration (FDA) Turn Its Back on Black Men with Non-Approval of First-Ever Prostate Cancer Vaccine? - Clinical Trial Research
Cognis Nutrition & Health receives Frost & Sullivan award for its Brand Development Strategy Leadership - Drug Development
FDA Takes Action to Stop Marketing of Unapproved Timed-Release Guaifenesin Drug Products - Drug Development
Neurogen Files Universal Shelf Registration Statement - Glaucoma
Scientists at University of Zurich, Department of Ophthalmology publish new data on glaucoma - More from this issue of Drug Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
